Page 454 - 30917_ASHG_Complete

This is a SEO version of 30917_ASHG_Complete. Click here to view full version

« Previous Page Table of Contents Next Page »
ICHG oral sessions have indicated a relationship that, in the context of th
presentation, could be perceived by some as a real or apparent conflict of inter
but do not consider that it will influence their presentation. The disclosures have be
reviewed and conflicts of interest disclosed. The number following each compa
name represents the specific relationship from the list above. If a presentation is i
platform, it was selected for oral presentation from a submitted abstract and t
abstract number is added in parenthesis. If an organizer or a presenter is not liste
then he/she had no relationship to disclose.
Abecasis, G., GlaxoSmithKline - 2 (Session 48)
Akbaroghli, S., State Welfare Organization - 3
(1038W)
Albert, T., Roche - 3 (847T)
Antonacci, F., Signature Genomic Laboratories - 12
(887W)
Arezi, B., Agilent Technologies - 3 (926T)
Arn, P., Genzyme - 5, 14 (1309T)
Ballabio, A., Biomarin - 2 (Session 63)
Ballif, B. C., Signature Genomic Laboratories,
PerkinElmer Inc. - 3; Cleveland Clinic - 3; SSM
Cardinal Glennon Children’s Medical Center - 3
(1463T)
Barnholt, K. E., 23andMe, Inc. - 1, 3 (1391F)
Barrett, J., Illumina - 12 (Session 48)
Baumbach-Reardon, L. L., Muscular Dystrophy
Aassociation - 2; Families of SMA - 6 (Session 7)
Bergstrom Lucas, A., Agilent Technologies - 3 (861F)
Betley, J., Illumina - 3 (1191W)
Bickmore, W., Roche Nimblegen - 12 (Session 26)
Biesecker, L. G., Illumina Corp - 6 (1)
Bishop, J., Life Technologies - 1, 3, 10 (927T)
Boland, J., Fluidigm - 3 (929T)
Bolz, H. J., Bioscientia - 3 (1148T)
Botton, M. R., CNPq - 2 (1392F)
Bourgeois, S., University of Washington - 10 (1393F)
Brayer, J. A., RainDance Technologies - 3 (1368F)
Brownstein, C., PatientsLikeMe - 1, 2 (47)
Burghes, A., BioMarin Pharmaceutical - 5; ShireHGT -
5 (Session 7)
Burn, J., QuantuMDx - 3, 4, 10 (264)
Carlson, C. S., Adaptive TCR Corporation - 4, 5, 7, 10
(817F)
Caruccio, N. C., Epicentre - An Illumina Company - 3
(1380F)
Casuga, I., Life Technologies - 3 (927W)
Chakravarti, A., Affymetrix, Inc. - 11 (Session 24)
Charland, S. L., Medco Health Solutions, Inc. - 1, 3
(1379T)
Chasman, D., AstraZeneca - 2 (150)
Chen, Z., Life Technologies - 3, 1, 10 (939W)
Chenchik, A., Cellecta, Inc. - 1, 3, 4, 13 (1210W)
Chiu, R., Sequenom - 1, 2, 7, 12; Illumina - 14; Life
Technologies - 14 (Session 29)
Coffeen, C., Esoterix Genetic Laboratories, LLC - 3
(1380W)
Cook-Deegan, R., Nat Human Genome Res Inst - 2
Kauffman Foundation - 2; The Duke Endowment
2; Duke University - 3 (Session 44)
Cornejo, M., Fogarty International Research Progra
in Peru, UW - 2 (567F)
Costa, P., Agilent Technologies - 3 (1457T)
Davidson, C., Life Technologies - 3 (928W)
Day-Williams, A. G., deCODE Genetics - 1, 3;
AstraZeneca - 1, 3 (689T)
De La Vega, F., Omicia, Inc. - 1, 3, 12 (853T)
de Paor, A., Irish Research Council for the Humaniti
& Social Sciences - 2; Centre for Disability Law a
Policy - 11 (1342T)
Diatchenko, L., Algynomics - 1, 4, 5, 6, 10, 12;
Attagene - 1, 4 (Session 5)
Dickson, P. I., Biomarin - 2; Genzyme - 2 (1313T)
Do, C. B., 23andMe, Inc - 1, 3 (408W)
Dorman, S. N., Cytognomix Inc. - 10, 13 (1276F)
Drmanac, R., Complete Genomics - 1, 3, 6 (Sessio
43)
Eberle, M. A., Illumina - 1, 3 (415F)
Ehm, M. G., GlaxoSmithKline - 1, 3 (205)
Eichler, E. E., Pacific Biosystems - 1, 5, 11 (Sessio
66)
Elboudwarej, E., Glaxo Smith Kline - 5; Novartis - 5
Sanofi-aventis - 5; Genentech - 5 (760W)
Eriksson, N., 23andMe - 1, 3 (430T)
Erskine, K. E., National Heart, Lung, and Blood
Institute/NIH - 2 (366W)
Evans, M., Ikonysis - 1; Perkin Elmer - 5 (Session 2
Feinerman, B. V., Stem Cell Regen, Inc. - 1 (1480F)
Feng, J., Amicus Therapeutics - 3 (1459F)
Fernhoff, P., Amicus Therapeutics - 2 (1460F)
Fijal, B., Eli Lilly & Co. - 1, 3 (1399F)
Fish, R., Life Technologies - 3 (931T)
Fisher, S., Illumina, Inc. - 12 (932T)
Fitch, K., CardioDx, Inc - 1, 3; Illumina, Inc - 1, 3
(427W)
Friedrich, D. C., CNPq - 2 (477W)
Gallie, B. L., Retinoblastoma Solutions - 6; Solution
by Sequence - 6, 4 (324)
Garcia, S. T. K., 23andMe - 1 (1347T)
Geschwind, D., SynapDx - 11 (Session 66)
Ghadirkhomi, E., ACECR - 3 (1274W)
Ghosh, S., Section on Statistical Genetics and
Genetic Epidemiology - 15; Reviewer of abstract
(472F); Complete Genomics - 1, 3 (812W)